News
Shortcuts from other journals
New antifungal looks safer than liposomal amphotericin B
BMJ 2007; 334 doi: https://doi.org/10.1136/bmj.334.7600.926-a (Published 03 May 2007) Cite this as: BMJ 2007;334:926
Micafungin is the newest in a class of antifungal agents called echinocandins. A recent trial showed that it works as well as liposomal amphotericin B, but has a significantly better safety profile when used to treat patients with invasive …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.